Tango Therapeutics

IPO

Discovering the next generation of precision cancer medicines

Public · Cambridge, United States · Founded 2017 · $235.0M raised

Employees
51–200
Founded
2017
Business Model
B2B
Total Funding
$235.0M
Last Round
$120.0M Series CMay 2025
Rounds
3
Type
Public

About

Tango Therapeutics is a clinical-stage biotechnology company leveraging the principle of synthetic lethality to discover novel drug targets and develop precision cancer medicines. The company's integrated discovery platform uncovers vulnerabilities arising from tumor suppressor gene loss in specific cancer types, enabling targeted therapies for genetically defined patient populations with limited treatment options.

Summary

Tango Therapeutics is a Biotech company based in Cambridge, United States, founded in 2017. It has raised $235.0M in total across 3 rounds, most recently a $120.0M Series C round in May 2025. Investors include Boxer Capital, BCTG Acquisition Corp. and Third Rock Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Secondary MarketSecondary MarketOct 2025

Sign up to see all 5 rounds

Series A through Secondary Market — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tango Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/tango-therapeutics"><img src="https://indexed.vc/api/badge/company/tango-therapeutics" alt="Tango Therapeutics on Indexed.vc" width="260" height="76" /></a>